Tofacitinib combined with local low-dose ixekizumab injection benefits those with peripheral psoriatic arthritis

Ruiyuan Xia; Weixin Zhang; Jing Hang; Zhiqiang Yin

doi:10.7555/JBR.37.20220253

Journal of Biomedical Research ›› 2024, Vol. 38 ›› Issue (1) :92 -94. DOI: 10.7555/JBR.37.20220253

Letter to the Editor

research-article

Tofacitinib combined with local low-dose ixekizumab injection benefits those with peripheral psoriatic arthritis

Author information +

History +

PDF (2057KB)

Cite this article

Download citation ▾

Ruiyuan Xia, Weixin Zhang, Jing Hang, Zhiqiang Yin. Tofacitinib combined with local low-dose ixekizumab injection benefits those with peripheral psoriatic arthritis. Journal of Biomedical Research, 2024, 38(1): 92-94 DOI:10.7555/JBR.37.20220253

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	García-Vicuña R, Garrido N, Gómez S, et al. Management of particular clinical situations in psoriatic arthritis: an expert's recommendation document based on systematic literature review and extended Delphi process[J]. Rheumatol Int, 2021, 41(9): 1549-1565. doi: 10.1007/s00296-021-04877-5

[2]	Jones RGA, Martino A. Targeted localized use of therapeutic antibodies: a review of non-systemic, topical and oral applications[J]. Crit Rev Biotechnol, 2016, 36(3): 506-520. doi: 10.3109/07388551.2014.992388

[3]	He F, Long F, Tu J, et al. Intramatricial low-dose secukinumab injection for nail psoriasis[J]. Indian J Dermatol Venereol Leprol, 2021, 87(1): 116-119. doi: 10.4103/ijdvl.IJDVL_124_20

[4]	He F, Long F, Zhang Z, et al. Intramatricial injection of anti-interleukin-17A antibody for six patients with nail psoriasis[J]. Clin Exp Dermatol, 2022, 47(2): 432-433. doi: 10.1111/ced.14933

[5]	He F, Long F, Yin Z, et al. Local injection of low-dose ixekizumab for the treatment of palmoplantar pustular psoriasis[J]. Int J Dermatol, 2022, 61(6): 742-743. doi: 10.1111/ijd.16185

[6]	Balato N, Napolitano M, Ayala F, et al. Nonalcoholic fatty liver disease, spleen and psoriasis: new aspects of low-grade chronic inflammation[J]. World J Gastroenterol, 2015, 21(22): 6892-6897. doi: 10.3748/wjg.v21.i22.6892